World Pharma Newsfeed
Preventing and treating drug use with smartphones
Clinical researchers at the University of Massachusetts Medical School (UMMS) are combining an innovative constellation ...
FDA acts to bolster supply of critically needed cancer drugs
The U.S. Food and Drug Administration announced a series of steps to increase the supply of critically needed cancer dru...
How good cholesterol turns bad
Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have found n...
BRILINTA® added to American College of Chest Physicians recommendations
AstraZeneca (NYSE: AZN) announced that the American College of Chest Physicians (ACCP) has updated its guidelines on Ant...
Pfizer and Hisun announce progress on potential joint venture
Pfizer Inc. (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading pharmaceutical company in China,...
Positive One Year results From Phase 3 Study in Central Retinal Vein Occlusion of VEGF Trap-Eye
Top-line results with VEGF Trap-Eye (aflibercept injection) after one year of treatment in the Phase 3 GALILEO study in ...
Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
The Bristol-Myers Squibb Foundation has awarded three new grants to improve prevention, diagnosis and care of hepatitis ...
EU and US Regulatory Update - Tykerb/Tyverb® (lapatinib)
GlaxoSmithKline has submitted regulatory applications in Europe and the US related to Tykerb/ Tyverb (lapatinib) and its...
Positive top-line result for UCB's Cimzia® in psoriatic arthritis
UCB intends to submit regulatory applications for Cimzia® (certolizumab pegol) in psoriatic arthritis, by end of 2012. T...
Video games lead to new paths to treat cancer
In a research lab at Wake Forest University, biophysicist and computer scientist Samuel Cho uses graphics processing uni...
